The Cost of Chronic Disease and the Future of Treatment
The increasing prevalence of chronic diseases—including diabetes, heart disease, and multiple types of cancer—is a global trend that has seen a sharp rise in the MENA region. Experts will examine risk factors, discuss future trends, and identify responses to reduce the regional chronic disease burden. Discussion will focus on the role that public education, lifestyle behaviors, science, and technology—such as genomic data and gene therapy—can play in terms of preventing obesity and reducing the cost of chronic disease.
Moderator:
Hugh Waters
Director, Health Economics Research, Milken Institute
Speakers:
Hawaa Althahak Almansoori
Consultant Endocrinologist and Deputy Medical Director, Imperial College London Diabetes Centre Abu Dhabi
Sumit Jamuar, Chairman and CEO, Global Gene Corp
Nancy Knight
Director, Division of Global Health Protection, Center for Global Health, Centers for Disease Control and Prevention (CDC)
Freda Lewis-Hall
Executive Vice President and Chief Patient Officer, Pfizer